1229607-63-9Relevant academic research and scientific papers
P38 MAP KINASE INHIBITORS
-
Page/Page column 59, (2010/07/02)
The present disclosure relates to compounds of formula (I): which are inhibitors of p38 mitogen-activated protein kinase enzymes,particularly the alpha and gamma kinase sub-types thereof, and their use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as COPD
